34 reports

China and South Korea, for example, have managed to control the spread of the disease by implementing severe countermeasures, such as strict travel restrictions; imposing city-wide quarantines, curfews, and lockdowns; building specialty hospitals; increasing medical aid; and rampin

  • Molecular Diagnostics
  • North America
  • United States
  • Market Size
  • Abbott Laboratories, Inc.

OTHERS GLOBAL PNEUMONIA TESTING MARKET BY TECHNOLOGY 2016 GLOBAL PNEUMONIA TESTING MARKET SEGMENTATION BY END-USERS 2016 PART ##: Market segmentation by end-user HOSPITALS HOSPITALS SUCH AS MULTI-SPECIALTY HOSPITALS AND HOSPITAL GROUPS WORK UNDER GOVERNME

  • Immunodiagnostics
  • Infectious Disease
  • Molecular Diagnostics
  • Roche Group
  • Thermo Fisher Scientific, Inc.

Acquisition of small hospitals by Tier ## hospitals Source: Technavio Number of hospitals merged and acquired between 2010 and 2015 in US M& AS OF SMALLER AND MEDIUM-SIZED HOSPITALS BY LARGE MULTI-SPECIALITY HOSPITALS HAVE HELPED TO EX

  • Molecular Diagnostics
  • Prosthesis
  • Illumina, Inc.
  • Immucor, Inc.
  • Thermo Fisher Scientific, Inc.

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Biomarker
  • Laboratory
  • Molecular Diagnostics
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Biomarker
  • Laboratory
  • Molecular Diagnostics
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Biomarker
  • Laboratory
  • Molecular Diagnostics
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostics
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostics
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Diagnostics
  • Laboratory
  • Molecular Diagnostics
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

  • Laboratory
  • Molecular Diagnostics
  • Point Of Care Testing
  • United States
  • Market Size

The Company operates in three segments: Analytical Technologies, Specialty Diagnostics and Laboratory Products and Services.

  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Market Size
  • Roche Group

The Company operates in three segments: Analytical Technologies, Specialty Diagnostics and Laboratory Products and Services.

  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Market Size
  • Roche Group

The Company operates in three segments: Analytical Technologies, Specialty Diagnostics and Laboratory Products and Services.

  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Market Size
  • Roche Group

The Company operates in three segments: Analytical Technologies, Specialty Diagnostics and Laboratory Products and Services.

  • Medical Biotechnology
  • Molecular Diagnostics
  • United States
  • Market Size
  • Roche Group

SCREENING MARKET ##. ##. ## INCREASING NUMBER OF SURGICAL PROCEDURES WILL DRIVE THE This end-user segment includes big hospitals and specialty hospitals.

  • Molecular Diagnostics
  • North America
  • United States
  • Market Size
  • Roche Group

Multispecialty hospitals, cancer specialty hospitals, or cancer treatment centers generally consist of laboratories that can perform various types of diagnostic and monitoring tests and develop personalized medicine treatments for cancers.

  • Leukemia
  • Molecular Diagnostics
  • North America
  • United States
  • QIAGEN N.V.

SPECIALTY DIAGNOSTICS SEGMENT SPECIALTY DIAGNOSTICS SEGMENT REVENUE INCREASED ##% TO $##. ## BILLION IN THE FIRST QUARTER OF 2019, COMPARED WITH REVENUE OF $##. ## BILLION IN THE FIRST QUARTER OF 2018.

  • Hormone
  • Molecular Diagnostics
  • China
  • East Asia
  • Market Size

Currently, there are ##, ## specialty centers and ##, ## veterinary clinics in Spain.

  • Cattle
  • Molecular Diagnostics
  • North America
  • United States
  • Market Size

HF LEADS TO NEARLY ONE MILLION HOSPITAL ADMISSIONS A YEAR AND IS ONE OF THE LEADING COSTS AND KILLERS IN THE UNITED STATES. "

  • Clinical Trial
  • Molecular Diagnostics
  • Company
  • Company Financials
  • Demand

In partnership with India' s largest cancer specialty hospital network, Health Care Global (HCG), Strand Ramanujan will create a clinical genomics data bank that will advance genomic medicine in oncology.

  • Healthcare
  • Molecular Diagnostics
  • Pharmaceutical
  • India
  • Deals & Alliance

THE RISING NUMBER OF NEW MULTI-SPECIALTY HOSPITALS IN INDIA IS ALSO SUPPORTING THE GROWTH OF THE PERSONALIZED MEDICINE AND GENOTYPING MARKETS IN THE COUNTRY.

  • Genome Sequencing
  • Molecular Diagnostics
  • Forecast
  • Market Size
  • Thermo Fisher Scientific, Inc.

The company also offers its services to acute care and specialty hospitals sectors which include LTACH, psychiatric, rehabilitation and sub-acute facilities, medical laboratories and large physician groups, among others.

  • Molecular Diagnostics
  • United States
  • Company
  • Company Financials
  • CareDx, Inc.

It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and long-term care centers, community health centers and other healthcare entities.

  • Genomics Proteomics And Enabling Technology
  • Molecular Diagnostics
  • United States
  • Company
  • Illumina, Inc.